Delivery Order SPE2DB22D1041-SPE2DB25FUAP8
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,157.75 firm fixed-price delivery order is for 4,564,886,290 tablets of the drug Lisinopril 10 mg. The contract has a completion date of June 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award, valued at $9,085.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract for the supply of 4,565,079,360 tablets of Lisinopril 10 mg, a common cardiovascular medication. The contract has an ultimate completion date of July 8, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,654.66, is a delivery order for 4,563,436,091 tablets of the generic drug Lisinopril 10 mg. The award has an ultimate completion date of January 25, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,487.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Lisinopril, a cardiovascular medication, with a completion date of November 19, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of the medication Lisinopril 40 mg tablets. The contract has a firm fixed price of $1,053.60 and a completion date of May 6, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award, valued at $1,243.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,560,701,371 units of Lisinopril 20 mg tablets, a cardiovascular medication, with an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,595.76 Firm Fixed Price Delivery Order contract is for the supply of 4,564,309,749 Lisinopril 40 mg tablets. The contract has an ultimate completion date of April 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,556 units of Lisinopril-HCTZ 20-12.5 mg tablets in 1,000 count bottles. The $1,418.22 firm-fixed price delivery order has an ultimate completion date of August 26, 2024. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for supplying a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,989.87, is a delivery order for Lisinopril 10 mg tablets. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,377,307 units of the prescription drug Lisinopril 40 mg tablets. The contract, valued at $2,632.97, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major Defense agency, on a full and open competition basis without any set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...